TDOC Company Profile and Key Details

Q: Who are the executives of TDOC?

Ms. Courtney Kraemer McLeodDirector of CommunicationMr. Claus Torp Jensen Ph.D.Chief Innovation OfficerMr. Jason Nathanial GorevicChief Executive Officer & DirectorMr. Adam Christian VandervoortChief Legal Officer & Sec.Dr. George Byron BrooksCo-FounderMr. Andrew TuritzExecutive Vice President of Corporation Devel.Ms. Mala MurthyChief Financial OfficerMr. Richard J. NapolitanoSenior Vice President, Chief Accounting Officer & ControllerMr. Laizer D. KornwasserPres of Enterprise Growth & Global MarketsDr. Claus Torp Jensen Ph.D.Chief Innovation OfficerMr. Mike WatersChief Operating OfficerMr. Patrick Thomas Feeley C.F.A., CPAVice President of Investor RelationsMs. Stephany VerstraeteChief Marketing Officer & Engagement OfficerMr. Michael WatersChief Operating Officer

NYSE : TDOC

Teladoc Health

$5.54

-0.005-0.09%

Open: 10:37 AM

62.23

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Teladoc Health, Inc. (TDOC) stock declined over -0.09%, trading at $5.54 on NYSE, down from the previous close of $5.54. The stock opened at $5.60, fluctuating between $5.50 and $5.65 in the recent session.

Stock Snapshot

5.54

Prev. Close

987.42M

Market Cap

5.495

Day Low

-0.16

P/E Ratio

-34.2

EPS (TTM)

1.17

Cash Flow per Share

5.6

Open

178.4M

Number of Shares

5.65

Day High

98.9%

Free Float in %

14.01

Book Value

550.41K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 14, 2026	5.30	5.44	5.20	5.24	3.04M
Apr 13, 2026	5.01	5.25	4.97	5.22	4.07M
Apr 10, 2026	5.27	5.30	5.06	5.10	3.24M
Apr 09, 2026	5.20	5.29	5.14	5.25	5.47M
Apr 08, 2026	5.60	5.70	5.21	5.27	4.45M
Apr 07, 2026	5.25	5.36	5.17	5.32	3.41M
Apr 06, 2026	5.26	5.41	5.25	5.32	2.19M
Apr 02, 2026	5.15	5.37	5.07	5.27	3.49M
Apr 01, 2026	5.52	5.59	5.26	5.28	4.89M
Mar 31, 2026	5.22	5.47	5.12	5.45	7.7M
Mar 30, 2026	5.13	5.22	5.05	5.14	3.84M
Mar 27, 2026	5.44	5.47	5.12	5.14	4.5M
Mar 25, 2026	5.54	5.61	5.39	5.57	4.41M
Mar 24, 2026	5.36	5.50	5.33	5.42	3.82M
Mar 23, 2026	5.44	5.60	5.32	5.48	4.62M
Mar 20, 2026	5.49	5.53	5.29	5.35	6.09M
Mar 19, 2026	5.35	5.57	5.35	5.52	3.7M
Mar 18, 2026	5.46	5.57	5.40	5.42	3.41M
Mar 17, 2026	5.44	5.68	5.43	5.61	5.15M
Mar 16, 2026	5.43	5.50	5.36	5.39	3.22M

Contact Details

Purchase, NY 10577

United States

https://www.teladochealth.com 203 635 2002

About Company

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.

Stock Peers

VEEV

0.64+0.40%

Veeva Systems Inc.$159.09 HNGE

0.95+2.51%

Hinge Health, Inc.$38.78 MPLN

-0.36-1.53%

MultiPlan Corporation$23.15 DOCS

-0.41-1.81%

Doximity, Inc.$22.25 CTEV

0.77+4.43%

Claritev Corporation$18.14 AGTI

-0.05-0.50%

Agiliti, Inc.$10.05 PHR

0.04+0.47%

Phreesia, Inc.$8.60 AMWL

-0.04-0.72%

American Well Corporation$5.51 EVH

-0.02-0.79%

Evolent Health, Inc.$2.51 UPH

0.0251+9.13%

UpHealth, Inc.$0.30

Company Overview

The stock is currently mid-range between its 52-week high and low $4.40 and $9.77. With a market capitalization of about $987.42 million, Teladoc Health, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~2.08). Key stats such as the average daily volume over the past year has been around 6.12 million shares, volume is running light vs its 52-week average. Headquartered in Purchase, NY, Teladoc Health, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Teri Condon, the company employs approximately 4,620 people and listed since June 30, 2015. Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally.

Technical Performance

TDOC has shown weak momentum, losing -16.28% over the past week and -28.84% over the past quarter, though year-to-date performance is down -13.29%. Short-term trend indicators are bullishly aligned (SMA20 9.35%, SMA50 -12.43%, SMA200 -27.13%). The stock’s 14-day RSI is 51.75 (neutral), while the ATR of 0.32 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -53.68% below its high and over 21.59% above its low. Average 10-day trading volume of 3.70 million shares is below the 3-month average of 6.22 million, indicating normal recent market interest.

Valuation Metrics

Teladoc Health, Inc. trades at a P/E ratio of -4.6, slightly below the S&P 500 average, with a price-to-sales ratio of 0.37 and a price-to-book ratio of 0.66 suggesting the stock is closer to book value. The P/FCF stands at 4.1, also above market averages.

Dividend & Fair Value

Teladoc Health, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $23.92. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Teladoc Health, Inc. generated EPS of -$1.28 over the past year. Five-year average earnings growth is -33.66%. Wall Street analysts project EPS growth of 35.74% annually over the next five years. The latest quarter delivered EPS of -$0.28. The next quarter is forecast at -$0.26. Next year's EPS is expected at $13.28. Analyst sentiment is neutral. Analyst rating data shows there are 2 Strong Buy ratings, 3 Buy ratings, 20 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $12.00 to $6.00. The high target offers 129.01% upside. The low target suggests 14.5% downside. The mean target is $8.98. This offers 71.37% upside. Teladoc Health, Inc. earnings surprise history is a mixed track record. The quarter that ended October 29, 2025, missed forecasts by 7.69%. The prior quarter beat by -29.63%. Over the last six quarters, Apple has recorded several small beats. These include -22.22% in July 31, 2024.

Shareholding & Insider Activity

Teladoc Health, Inc. has 176.69 million shares outstanding. The public float is 174.77 million shares, elevated short interest at 14.95% of float. This equals 23.62 million shares. The short ratio is 3.1 days. Institutional investors hold 72.77% of the float. Insiders own 1.01%. GOREVIC JASON N holds 653.07 thousand shares, DIVITA CHARLES III has 364.78 thousand shares and Murthy Mala has 142.38 thousand shares. Over the past six months, insider transactions show net selling. They sold 172.24 thousand shares across 13 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Teladoc Health generated $2.60B in revenue, or $15.81 per share. Gross margin was 70.80%, operating margin -9.55%, and net profit margin -8.47%. Returns are negative, with ROA at -5.02% and ROE at -9.47%.
On valuation metrics, Teladoc Health trades at a P/E of -4.60, P/S of 0.37 and P/B of 0.66. The current ratio is 2.69 and quick ratio is 2.59. Operationally, the company’s inventory turnover is 20.20 and cash conversion cycle is 24.47 days. Debt-to-equity is 0.75, supported by a cash flow-to-debt ratio of 0.28.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Teladoc Health posted revenue of $2.60B, down slightly from $2.41B in the prior quarter. Gross profit was $1.84B (margin 70.80%). Operating income was - $248.55M (margin -9.6%). Net income was- $220.37M (EPS - $1.34).
The company ended the quarter with $1.12B in cash and short-term investments, a total debt of $1.59B, and net debt of $468.60M. Total assets were $4.39B, with equity of $2.33B. Financials further reflected stability, with operating cash flow of $350.02M, free cash flow of $193.67M, and capital expenditures of - $156.35M.

Price Forecast & Outlook

Our AI price prediction model suggests that Teladoc Health, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -1.72%, with price expected at $5.15 by April 28, 2026, within a range of $4.95 to $5.33 3-Month Outlook: Projected rise of 91.6%, reaching $10.04 by July 13, 2026, with a range of $9.12 to $10.68. 1-Year Outlook: Projected gain of 1.91%, with price at $5.34 by April 14, 2027, within a range of $0.00 to $2.45.

Key Takeaways

Teladoc Health, Inc. (NYSE:TDOC) shares are down -13.29% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Teladoc Health, Inc. trading at a premium to the broader market with a P/E of -4.6. Analyst sentiment is cautious, with the majority of ratings in In-Line territory and a mean price target of $21.08, suggesting 302.29% upside. Our AI forecast model points to short-term weakness (-1.72% over two weeks), a medium-term rise (91.6% over three months), and a longer-term gain (1.91% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Teladoc Health, Inc. (TDOC) stock price?

Teladoc Health, Inc. (NYSE: TDOC) stock price is $5.54 in the last trading session. During the trading session, TDOC stock reached the peak price of $5.65 while $5.50 was the lowest point it dropped to. The percentage change in TDOC stock occurred in the recent session was -0.09% while the dollar amount for the price change in TDOC stock was - $0.01.

TDOC's industry and sector of operation?

The NYSE listed TDOC is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. Teladoc Health, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TDOC?

Ms. Courtney Kraemer McLeod
Director of Communication
Mr. Claus Torp Jensen Ph.D.
Chief Innovation Officer
Mr. Jason Nathanial Gorevic
Chief Executive Officer & Director
Mr. Adam Christian Vandervoort
Chief Legal Officer & Sec.
Dr. George Byron Brooks
Co-Founder
Mr. Andrew Turitz
Executive Vice President of Corporation Devel.
Ms. Mala Murthy
Chief Financial Officer
Mr. Richard J. Napolitano
Senior Vice President, Chief Accounting Officer & Controller
Mr. Laizer D. Kornwasser
Pres of Enterprise Growth & Global Markets
Dr. Claus Torp Jensen Ph.D.
Chief Innovation Officer
Mr. Mike Waters
Chief Operating Officer
Mr. Patrick Thomas Feeley C.F.A., CPA
Vice President of Investor Relations
Ms. Stephany Verstraete
Chief Marketing Officer & Engagement Officer
Mr. Michael Waters
Chief Operating Officer

How TDOC did perform over past 52-week?

TDOC's closing price is 19.09% higher than its 52-week low of $4.40 where as its distance from 52-week high of $9.77 is -46.37%.

How many employees does TDOC have?

Number of TDOC employees currently stands at 4,620.

Link for TDOC official website?

Official Website of TDOC is: https://www.teladochealth.com

How do I contact TDOC?

TDOC could be contacted at phone 203 635 2002 and can also be accessed through its website. TDOC operates from 2 Manhattanville Road, Purchase, NY 10577, United States.

How many shares of TDOC are traded daily?

TDOC stock volume for the day was 550.41K shares. The average number of TDOC shares traded daily for last 3 months was 6.12M.

What is the market cap of TDOC currently?

The market value of TDOC currently stands at $987.42M with its latest stock price at $5.54 and 178.4M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	4620
Beta	2.08
Sales or Revenue	$2.60B
5Y Sales Change%	1.528%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Healthcare Information Services

TDOC Company Profile and Key Details

Teladoc Health

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Stock Snapshot

Company Overview

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Earnings & Analyst Outlook

Price Forecast & Outlook

Key Takeaways

Valuation Metrics